| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/01/2001 | EP1119334A1 Two chamber cartridge for atomizers |
| 08/01/2001 | EP1119321A1 Patient temperature regulation method and apparatus |
| 08/01/2001 | EP1119256A1 Oral combination of lufenuron and nitenpyram against fleas |
| 08/01/2001 | EP1119255A2 Novel compositions and methods for prevention and treatment of protozoal disease |
| 08/01/2001 | EP1119254A1 Novel treatment for stroke management |
| 08/01/2001 | EP1119252A2 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 08/01/2001 | EP1119251A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof |
| 08/01/2001 | EP1119248A1 Hydroxystilbene compounds used as microbicidal active substances |
| 08/01/2001 | EP1037627B1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid and of pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment of non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 08/01/2001 | EP0906324B1 Carbohydrate derivatives and their solid-phase synthesis |
| 08/01/2001 | EP0885013B1 Use of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses for the preparation of medicaments |
| 08/01/2001 | EP0877737B1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 08/01/2001 | EP0862567B1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 08/01/2001 | EP0806963B1 Carcinoma treatment |
| 08/01/2001 | EP0760675B1 Compositions comprising dna damaging agents and p53 |
| 08/01/2001 | EP0748218B1 Plaster-shaped transdermal system with a tamoxifen derivative |
| 08/01/2001 | EP0742712B1 Bilayered amoxycillin tablets |
| 08/01/2001 | EP0719268B1 K-252a DERIVATIVES WHICH ENHANCE NEUROTROPHIN-INDUCED ACTIVITY |
| 08/01/2001 | EP0691846B1 Imidazolo-quinoxalinones for treating diseases of the central nervous system |
| 08/01/2001 | EP0631503B1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 08/01/2001 | EP0625984B1 Cephalosporin compounds |
| 08/01/2001 | CN1306580A Mumbaistatin, process for its prodn. and its use as pharmaceutical |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306569A Stabilized transient gene expression |
| 08/01/2001 | CN1306536A Propenyl cephalosporin derivatives |
| 08/01/2001 | CN1306535A Thienopyridine compounds, their prodn. and use |
| 08/01/2001 | CN1306534A Thienopyrimidines |
| 08/01/2001 | CN1306533A Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 08/01/2001 | CN1306532A Novel pyrrolo-(3,4-B) quinoline derivatives, method for prodn. and use thereof as medicament |
| 08/01/2001 | CN1306531A Epothilones derivatives, their synthesis and uses |
| 08/01/2001 | CN1306530A Paroxetine 10-camphorsulfonate for treament of CNS disorders |
| 08/01/2001 | CN1306529A Novel form of irbesartan, methods for obtaining said form and pharmaceutical compsns. contg. same |
| 08/01/2001 | CN1306528A Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, its prodn. method and applications |
| 08/01/2001 | CN1306526A Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 08/01/2001 | CN1306525A Carboxylic acid of aza-heterocyclic compounds contg. multiple hetero-atoms or its electronic isosteric object |
| 08/01/2001 | CN1306515A Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1306511A Novel heterocyclic compounds |
| 08/01/2001 | CN1306509A Substituted benzamides, their prodn. and use as cysteine protease inhibitors |
| 08/01/2001 | CN1306508A Hydroxamic acid derivatives as inhibitors or prodn. of human CD23 and of TNF release |
| 08/01/2001 | CN1306505A Substituted benzamides, their prodn. and use |
| 08/01/2001 | CN1306504A Movel acyl pseudodipeoptides, prepn method and pharmaceutical compsns. contg. same |
| 08/01/2001 | CN1306503A 2-fluoro-2-alkyl alkanoamides with anticonvulsant activity |
| 08/01/2001 | CN1306436A Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/01/2001 | CN1306434A Compsn. for prevention and/or treatment of osteoporosis and alterations due to menopause syndrome |
| 08/01/2001 | CN1306432A Deoxy and oxygen-substituted sugar-contg. 14-aminosteriod compounds for use as antiarrhythmic |
| 08/01/2001 | CN1306431A Compsns. for increasing energy i(in vivo) |
| 08/01/2001 | CN1306430A Combinations comprising VX478, zidovuding and/or 1592U89 for use in treatment of HIV |
| 08/01/2001 | CN1306429A Use of glucocorticosteriod for mfg. medicament for treating mild/early forms of COPD (chronic obstructive pulmonary disease) |
| 08/01/2001 | CN1306428A Inhibitors of transcription factor NF-KB |
| 08/01/2001 | CN1306427A Acylbenzoxazines for enhancing synaptic response(s) |
| 08/01/2001 | CN1306426A Use of compounds for anti-pruritic activity |
| 08/01/2001 | CN1306425A Process for synthesizing Cox-2 inhibitors |
| 08/01/2001 | CN1306424A Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treatment of neurogenic inflammation |
| 08/01/2001 | CN1306423A Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 08/01/2001 | CN1306422A Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for treatment or prevention of diseases characterized by abnormal cell proliferation |
| 08/01/2001 | CN1306421A Matrix-type transdermal patch for steroid homones |
| 08/01/2001 | CN1306420A Methods for treating capules and dry powdered pharmaceutical formulations |
| 08/01/2001 | CN1306413A Foaming compsn. for hair care |
| 08/01/2001 | CN1306400A Drinks and foods capable of eliminating helicobacter pylori |
| 08/01/2001 | CN1306399A Additives for crustacean or fish feeds and feeds |
| 08/01/2001 | CN1306210A Comparative mark for larmour triazine |
| 08/01/2001 | CN1306009A Se-contained cyclodextrin and its application in preparing medicine to treat cataract |
| 08/01/2001 | CN1306003A Oligose with anticancer activity used as medicines or health-care products to improve immunity |
| 08/01/2001 | CN1305993A Cyclic guanyl preparation used as nitrogen oxide synthetic enzyme inhibitor |
| 08/01/2001 | CN1305989A Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 08/01/2001 | CN1305846A Diseases-resistant skin-protecting cream and its preparing process |
| 08/01/2001 | CN1305836A Medicine for treating epistaxis |
| 08/01/2001 | CN1305824A Medicine for treating piles |
| 08/01/2001 | CN1305813A Nail health disinfecting liquid |
| 08/01/2001 | CN1305812A N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines |
| 08/01/2001 | CN1305811A Medicinal composition and its antalgic purpose |
| 08/01/2001 | CN1305810A Antimalarial compound dihydroartemisinin |
| 08/01/2001 | CN1305806A Orally applied solid preparation of medicine difficult to dissolve |
| 08/01/2001 | CN1305805A Compsns. contg. ascorbic acid and pectin |
| 08/01/2001 | CN1305745A Process for preparing additive of food, medicines, or cosmetics to supplement linoleic acid and alpha-linoleic acid |
| 08/01/2001 | CN1069098C Novel imidazole derivative and process for producing same |
| 08/01/2001 | CN1069051C Exterior-applied limiment for treating hyperosteogeny |
| 08/01/2001 | CN1069050C Compounded Chinese medicine for treating diabetes |
| 08/01/2001 | CN1069049C Liquid for treating beriberi |
| 08/01/2001 | CN1069045C Oral liquid curing AIDS and its preparing method |
| 08/01/2001 | CN1069044C Injection for AIDS and prepn. thereof |
| 08/01/2001 | CN1069041C Traditional chinese medicine prepn. for eradicating helicobacter phlori |
| 08/01/2001 | CN1069033C Anti-parasite oral spray contg. evericin and ivermectin for sheep |
| 08/01/2001 | CN1069032C Antiparasitic medicine contg. avermectin/ivermectin for animals |
| 08/01/2001 | CN1069030C Multifunctional collyrium for women |
| 07/31/2001 | US6268533 Reacting 4-benzyloxy-3-formamidostyrene oxide with an optically pure 4-methoxy-.alpha.-methyl-n-(phenylmethyl)benzeneethanamine followed by reduction to produce formoterol |
| 07/31/2001 | US6268516 Cationic amphiphilic lipids for liposomal gene transfer |
| 07/31/2001 | US6268509 Parasiticidal pyrazoles |
| 07/31/2001 | US6268507 Hydantoin derivatives |
| 07/31/2001 | US6268502 Process of synthesis of 5-methoxy- 2-[(4-methoxy-3,5-dimethy-2-pyridyl)methyl]sulfiny-1h-benzimidazole |
| 07/31/2001 | US6268490 Bicyclonucleoside and oligonucleotide analogues |
| 07/31/2001 | US6268488 Active therapeutic agent attached to blocking moiety that is sensitive to catalytic action of molecules having retro-aldol and retro-michael catalytic activity; targeted antitumor, cytotoxic and antibiotic therapy |
| 07/31/2001 | US6268398 Aromatic guanidine derivatives |
| 07/31/2001 | US6268397 Alpha-(1-adamantylaminomethyl)3,4-dichlorobenzyl)thioacetamid e and its isomers, as well as the addition salts of these compounds |
| 07/31/2001 | US6268396 Administering 2-n-propyl-4-hexynoic acid |
| 07/31/2001 | US6268395 Phorbol derivatives having antivirus activity |
| 07/31/2001 | US6268394 Contacting a cell with an amount of a sesquiterpene lactone |
| 07/31/2001 | US6268393 Calanolides and analogues thereof |
| 07/31/2001 | US6268392 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |